Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

BACKGROUND: In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a potential window for vertical transmission. Insights into HBV seroprevalence in the vulnerable HIV-infected group are important to drive improvements in surveillance, treatment and prevention. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Jooste, Pieter, van Zyl, Anriette, Adland, Emily, Daniels, Samantha, Hattingh, Louise, Brits, Alethea, Wareing, Susan, Goedhals, Dominique, Jeffery, Katie, Andersson, Monique, Goulder, Philip, Matthews, Philippa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142290/
https://www.ncbi.nlm.nih.gov/pubmed/27838494
http://dx.doi.org/10.1016/j.jcv.2016.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142290/
https://www.ncbi.nlm.nih.gov/pubmed/27838494
http://dx.doi.org/10.1016/j.jcv.2016.10.017

Ejemplares similares